
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Emergent BioSolutions has acquired Cangene bioPharma. Emergent BioSolutions is a global specialty biopharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Emergents mission is simple - to protect and enhance life. Emergent BioSolutions contract manufacturing site (previously known as Cangene bioPharma) provides fill/finish services to pharmaceutical and biotechnology companies from its Baltimore, Maryland manufacturing plant. The contract manufacturing plant aseptically fills liquid and lyophilized products in vials and syringes. The site currently produces 24 commercial products and since 1990 has contributed to the development...
Contract manufacturing,aseptic fill/finish,liquid & lyophilized products,and vials and syringes
Cangene biopharma operates in the Pharmaceutical manufacturing industry.
Cangene biopharma's revenue is 11m - 100m
Cangene biopharma has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.